News|Articles|April 1, 2025
Pulmonology Month in Review: March 2025
Author(s)Victoria Johnson
Fact checked by: Chelsie Derman
This March 2025 month in review covers key pulmonology updates, including new findings on pulmonary function tests and expert insights from the AAAAI/WAO Joint Congress.
Advertisement
Advertisement
In March, the pulmonology field saw notable advancements in treatments and diagnostic insights. The FDA accepted Liquidia Corporation's resubmission for treprostinil inhalation powder (YUTREPIA), aiming for final approval to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Advertisement
Advertisement